Crossmark

Comparing the 2017 ASCO/CAP guideline for gastroesophageal adenocarcinoma surgical specimen to the 2018 ASCO/CAP guideline for breast cancer in assessing the HER2 status in primary mucinous ovarian carcinoma

Crossref DOI link: https://doi.org/10.1007/s00428-022-03285-9

Published Online: 2022-02-28

Published Print: 2022-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chao, Wan-Ru

Lee, Ming-Yung

Lee, Yi-Ju

Sheu, Gwo-Tarng

Han, Chih-Ping
Funding

Funding for this research was provided by:

Chung Shan Medical University Hospital (CSH‑2019‑C‑028, CSH‑2020‑C‑029, CSH-2021-C025, CSH-2022-C026)
License Information

Text and Data Mining valid from 2022-02-28

Version of Record valid from 2022-02-28
More Information

Article History

Received: 25 October 2021

Revised: 9 January 2022

Accepted: 19 January 2022

First Online: 28 February 2022

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below